For decades, depression was often explained through a relatively simple story: something had gone wrong with chemicals such as serotonin.
The reality is turning out to be considerably more complicated.
A major new study of the human hippocampus has found evidence that, in people with major depressive disorder (MDD), the process that generates new neurons appears to stall partway through development. At the same time, researchers discovered widespread changes involving inflammation, cellular stress, metabolism, synaptic plasticity and communication between brain cells. PubMed
The study, led by researchers at Columbia University and published in Nature Medicine on August 21, 2026, produced one of the most detailed molecular maps yet of the adult human hippocampus. National Institutes of Health
Its implications extend beyond understanding depression.
The molecular differences researchers discovered suggest that what we currently call “depression” could encompass multiple biological disturbances that may eventually require different treatments. Nature
Your Adult Brain Can Still Produce New Neurons
Most neurons in the human brain are created before birth.
But the hippocampus appears to be unusual.
Evidence increasingly indicates that a small population of neural stem and progenitor cells persists there during adulthood and can develop into new neurons—a process known as adult hippocampal neurogenesis. A separate 2026 Nature study also provided evidence for ongoing hippocampal neurogenesis throughout human adulthood. Nature
The hippocampus is deeply involved in learning and memory, but it also helps us process experiences and emotional information.
New neurons may therefore represent far more than replacement parts.
They could help keep hippocampal circuits flexible enough to adapt as we encounter new experiences.
That possibility has fascinated depression researchers for years.
Researchers Looked Directly Inside the Human Hippocampus
Much of what scientists know about adult neurogenesis comes from animal experiments.
The new research tackled the much harder question:
What actually happens in the brains of people with depression?
Researchers examined postmortem hippocampal tissue from 19 people without depression and 11 people who had major depressive disorder. Importantly, none of the donors with depression had taken antidepressants during the three months before death, reducing the likelihood that medication itself explained the differences. National Institutes of Health
They then applied an unusually extensive collection of molecular techniques.
These included single-nucleus RNA sequencing, chromatin-accessibility analysis, spatial transcriptomics and protein measurements. Altogether, the investigators analyzed approximately 495,000 brain-cell nuclei that passed their quality-control procedures. Nature
Instead of simply asking whether one particular gene was different, they could reconstruct entire cellular populations and examine what those cells were doing.
That’s when they noticed something peculiar.
People With Depression Had MORE Neural Stem Cells
At first, the result seems backward.
If depression interferes with the production of new neurons, you might expect depressed brains to contain fewer neural stem cells.
Researchers found the opposite.
People with depression had more cells displaying neural-stem-cell characteristics.
But farther along the developmental pathway, they had fewer intermediate cells—the cells that should appear as stem cells progress toward becoming mature neurons. National Institutes of Health
Imagine a factory.
Raw materials are arriving.
The first stage of production is operating.
But somewhere along the assembly line, production slows dramatically.
Products aren’t progressing normally toward completion.
That’s roughly what researchers believe may be occurring here.
The Neurons Seem to Get Stuck During Development
The team reconstructed what scientists call a neurogenic trajectory.
Neural stem cells don’t suddenly transform into mature neurons.
They pass through several developmental stages.
The researchers found evidence that this trajectory was disrupted in major depression, with the transition from neural stem cells toward intermediate progenitor stages appearing impaired. PubMed
Interestingly, the total number of mature neurons wasn’t dramatically different between the groups.
That makes sense because newly generated neurons represent only a tiny proportion of the enormous existing neuronal population.
But even a small stream of new neurons could potentially have an outsized influence on how hippocampal circuits adapt.
And that brings us to one of the study’s most intriguing ideas.
New Neurons May Help the Brain Separate Similar Experiences
One important function associated with the hippocampus is called pattern separation.
Suppose you once experienced something frightening in a particular place.
Months later, you encounter a situation that resembles it—but isn’t actually dangerous.
Your brain needs to distinguish:
“This resembles what happened before.”
from
“This is the same dangerous situation happening again.”
Animal research suggests newly generated hippocampal neurons contribute to pattern separation—the ability to distinguish between similar experiences and memories. The authors note that evidence from humans receiving focal hippocampal irradiation also supports a relationship between neurogenesis and pattern-separation performance. Hide Me
That becomes particularly interesting in depression.
Depression Often Pulls Memory Toward the Negative
People with major depression can exhibit negative memory bias—negative information and memories may receive disproportionate attention or be recalled more readily.
The hippocampus has long been implicated in these cognitive features of depression.
If neurogenesis is impaired, researchers hypothesize that the hippocampus may become less flexible when encoding new experiences and distinguishing them from old ones.
A new disappointing event could potentially become more strongly entangled with previous negative experiences.
That does not mean the study proves that stalled neurogenesis causes painful memories or depression.
The research examined postmortem tissue, so it cannot establish which change came first.
But it provides a plausible biological connection that scientists can now investigate experimentally. National Institutes of Health
The Discovery Was Much Bigger Than New Neurons
Neurogenesis produced the headline.
But researchers found alterations throughout the hippocampal molecular landscape.
In people with depression, there were signs involving:
cellular stress,
immune activation,
reduced metabolic capacity,
altered serotonin and glutamate signaling,
impaired synaptic plasticity,
and disrupted balance between excitatory and inhibitory neuronal activity. PubMed
In other words, the depressed hippocampus didn’t simply show one broken biological pathway.
Multiple systems appeared altered simultaneously.
That may help explain something psychiatrists have observed clinically for decades:
depression doesn’t behave like one uniform disease.
Some of the Strongest Signals Involved the Immune System
One particularly intriguing finding appeared in cells involved in neurogenesis.
Researchers detected increased activity in gene networks related to interferon signaling, an important component of the immune response.
Some altered genes have previously been associated with conditions involving inflammation or neurodegeneration, including lupus, Alzheimer’s disease and long COVID—conditions that can themselves involve cognitive or mood symptoms. National Institutes of Health
This doesn’t mean depression is simply an inflammatory disease.
But it adds to evidence that immune signaling may contribute to depression biology in at least some people.
And that’s where the research could eventually become clinically important.
“Depression” May Contain Several Different Biological Conditions
Imagine two people who receive exactly the same diagnosis.
Both meet clinical criteria for major depressive disorder.
One person’s illness might involve particularly strong immune-related abnormalities.
Another might show greater disruption in stress-response pathways.
Someone else could have abnormalities involving synaptic plasticity or metabolic function.
Their outward symptoms might overlap enough to receive the same diagnosis while the underlying biology differs substantially.
The new molecular atlas could eventually help researchers identify such biological subtypes of depression. Nature
That could fundamentally change how treatments are developed.
Why Antidepressants Work for Some People but Not Others
Current antidepressants are usually prescribed largely according to symptoms, previous responses, side effects and clinical judgment.
There isn’t yet a routine brain test that tells a psychiatrist:
“This person’s depression is primarily associated with biological pathway X, therefore treatment Y is most likely to work.”
Researchers would love to reach something closer to that level of precision.
Cancer medicine provides a useful analogy.
Two patients can have tumors arising in the same organ but receive different drugs because molecular testing reveals different cancer-driving mutations.
Psychiatry isn’t there yet.
But detailed molecular maps such as this one could help move research in that direction.
Could Scientists Restart Neurogenesis?
That’s one of the obvious questions raised by the study.
Study leader Maura Dupont suggested that restoring neurogenesis could potentially represent a treatment strategy for some people by helping rewire hippocampal circuitry. National Institutes of Health
But this remains a research hypothesis—not an available therapy.
Scientists would first need to determine whether disrupted neurogenesis contributes directly to depression or whether it is partly a consequence of other biological processes associated with the illness.
Then they would need to identify interventions capable of safely altering that process.
And critically, researchers would need to establish whether increasing neurogenesis actually improves symptoms in people.
Those are substantial unanswered questions.
The Study Also Strengthens a Long-Running Neuroscience Debate
Scientists have debated for years whether meaningful neurogenesis continues in the adult human hippocampus.
Some studies detected abundant immature neurons.
Others found little or no convincing evidence.
Differences in tissue preservation, markers, methodology and donor characteristics have contributed to the disagreement.
The new study adds unusually detailed molecular evidence for a developmental lineage extending from neural stem-like cells toward immature neurons in adult human hippocampal tissue. Nature
And it isn’t standing alone.
Earlier in 2026, another major study published in Nature examined postmortem hippocampi across adulthood, aging and Alzheimer’s disease and likewise reported evidence supporting ongoing adult hippocampal neurogenesis. Nature
Together, these studies are making the biological picture considerably clearer.
But There Is an Important Limitation
This was an extraordinarily detailed study.
It was not an extraordinarily large group of people.
The central comparison involved 11 donors with major depressive disorder and 19 controls. National Institutes of Health
That’s partly unavoidable.
Obtaining exceptionally well-preserved human hippocampal tissue with detailed clinical histories is difficult, and modern single-cell molecular analyses extract enormous amounts of information from each sample.
Still, replication in larger and more diverse cohorts will be essential.
Postmortem research also captures the brain at one moment.
It can’t show researchers exactly how these molecular changes evolved during a person’s illness.
Nor can it prove that stalled neurogenesis caused their depression. The researchers explicitly note that determining causality requires further work. National Institutes of Health
A Different Way of Thinking About Depression
Perhaps the most important part of the study isn’t any individual gene.
It’s the broader picture.
Major depression appears to involve alterations in the brain’s capacity for plasticity—its ability to change, reorganize and respond to experience.
New neurons may be one piece of that system.
Synaptic connections are another.
Stress signaling, metabolism, immune activity and neurotransmission may contribute too.
As Dupont put it, the field has moved beyond the older idea that depression is simply a deficiency of a neurotransmitter such as serotonin. cuimc.columbia.edu
The emerging picture is messier.
But scientifically, messier can be useful.
Because once researchers can identify the different biological pathways disrupted in different people, they can begin asking a much more powerful question than:
“What drug treats depression?”
They can ask:
“Which biological process is disrupted in this person’s depression—and how can we target it?”
That possibility remains years away from routine clinical practice.
But this new map of the human hippocampus provides researchers with something they haven’t previously had at this level of detail:
a cellular and molecular roadmap showing where depression may interrupt the brain’s ability to adapt, form new neurons and reshape itself in response to new experiences. Nature
For more fascinating insights into medical advancements, check out how a new experimental drug could help break cancer’s toughest defenses, or read about a major reanalysis finding that mammogram overdiagnosis may be far lower than previously thought.
